Loading...
Keywords
Last Name
Institution
 Back to Profile

Andrea Gaedigk

Concepts (578)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cytochrome P-450 CYP2D6
111
2024
184
21.720
 Why?
Pharmacogenetics
63
2024
176
11.000
 Why?
Alleles
63
2024
214
7.710
 Why?
Cytochrome P-450 Enzyme System
40
2024
96
7.660
 Why?
Genotype
112
2024
410
7.570
 Why?
Humans
216
2024
6896
5.790
 Why?
Haplotypes
28
2024
91
5.190
 Why?
Genetic Variation
32
2024
174
5.130
 Why?
Polymorphism, Genetic
33
2024
90
4.530
 Why?
Cytochrome P-450 CYP2C19
28
2024
60
4.050
 Why?
Genetic Testing
12
2024
87
3.480
 Why?
Polymorphism, Single Nucleotide
26
2021
348
3.260
 Why?
Aryl Hydrocarbon Hydroxylases
21
2024
45
3.150
 Why?
Cytochrome P-450 CYP3A
13
2023
46
3.150
 Why?
Phenotype
54
2024
257
2.870
 Why?
Polymerase Chain Reaction
24
2021
84
2.730
 Why?
Cytochrome P-450 CYP2C9
16
2022
25
2.720
 Why?
Gene Frequency
32
2021
90
2.710
 Why?
DNA Copy Number Variations
13
2023
37
2.630
 Why?
Dextromethorphan
30
2022
55
2.390
 Why?
Liver
19
2020
126
2.250
 Why?
Dihydrouracil Dehydrogenase (NADP)
3
2024
7
2.120
 Why?
Genotyping Techniques
10
2024
22
2.120
 Why?
Cytochrome P-450 CYP2B6
7
2024
11
2.010
 Why?
Terminology as Topic
6
2018
14
2.010
 Why?
High-Throughput Nucleotide Sequencing
5
2022
99
1.820
 Why?
Male
76
2021
3337
1.740
 Why?
Female
77
2021
3525
1.700
 Why?
Adult
53
2024
1181
1.470
 Why?
Databases, Genetic
3
2019
30
1.420
 Why?
Knowledge Bases
6
2024
7
1.380
 Why?
Child
49
2024
3364
1.330
 Why?
Reference Standards
3
2024
15
1.320
 Why?
Biotransformation
16
2020
49
1.320
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2022
23
1.320
 Why?
Precision Medicine
6
2024
45
1.300
 Why?
Analgesics, Opioid
10
2024
42
1.200
 Why?
Fluorouracil
2
2024
6
1.190
 Why?
Antidepressive Agents
6
2023
20
1.180
 Why?
Gene Duplication
5
2019
11
1.150
 Why?
Cytochrome P-450 CYP2A6
2
2024
4
1.130
 Why?
Pharmaceutical Preparations
9
2023
37
1.130
 Why?
Depressive Disorder, Major
4
2023
14
1.110
 Why?
Glucuronosyltransferase
6
2020
16
1.100
 Why?
Consensus
6
2024
35
1.080
 Why?
Pyrophosphatases
3
2022
4
1.080
 Why?
Adolescent
41
2024
2197
1.070
 Why?
Aging
7
2021
39
1.070
 Why?
Medication Therapy Management
3
2019
8
0.990
 Why?
Middle Aged
33
2021
608
0.970
 Why?
Gene Dosage
3
2021
13
0.940
 Why?
Tacrolimus
2
2022
10
0.930
 Why?
DNA
10
2023
41
0.920
 Why?
Codeine
8
2021
15
0.890
 Why?
Proton Pump Inhibitors
5
2024
18
0.850
 Why?
Inactivation, Metabolic
4
2021
15
0.850
 Why?
Cytochrome P-450 CYP2C8
1
2022
3
0.820
 Why?
Databases, Factual
2
2019
108
0.810
 Why?
Trichophyton
3
2007
5
0.810
 Why?
Alternative Splicing
4
2013
18
0.790
 Why?
RNA, Messenger
9
2017
115
0.790
 Why?
Child, Preschool
26
2022
1569
0.760
 Why?
Genetic Association Studies
3
2019
53
0.750
 Why?
Aged
18
2021
378
0.740
 Why?
Microsomes, Liver
10
2021
44
0.730
 Why?
Arylsulfotransferase
6
2011
8
0.730
 Why?
Molecular Sequence Data
16
2015
71
0.720
 Why?
Infant
24
2022
1446
0.710
 Why?
Young Adult
22
2022
647
0.710
 Why?
Genetics, Population
3
2016
11
0.680
 Why?
Infant, Newborn
18
2022
816
0.660
 Why?
Tinea
3
2007
4
0.640
 Why?
Atomoxetine Hydrochloride
4
2021
10
0.630
 Why?
Antipsychotic Agents
4
2021
14
0.630
 Why?
Venlafaxine Hydrochloride
1
2018
2
0.620
 Why?
Serotonin and Noradrenaline Reuptake Inhibitors
1
2018
4
0.610
 Why?
Omeprazole
7
2010
13
0.610
 Why?
Models, Biological
6
2021
65
0.590
 Why?
Hypercholesterolemia
3
2024
12
0.560
 Why?
DNA Mutational Analysis
2
2014
42
0.550
 Why?
Sequence Analysis, DNA
6
2018
115
0.550
 Why?
Bupropion
1
2015
3
0.530
 Why?
Base Sequence
13
2020
81
0.530
 Why?
Minor Histocompatibility Antigens
4
2020
12
0.520
 Why?
Arylamine N-Acetyltransferase
10
2010
18
0.510
 Why?
Oligonucleotide Array Sequence Analysis
2
2013
47
0.500
 Why?
2-Pyridinylmethylsulfinylbenzimidazoles
3
2022
6
0.490
 Why?
Anti-Ulcer Agents
4
2010
8
0.490
 Why?
MicroRNAs
4
2017
27
0.490
 Why?
Mixed Function Oxygenases
9
2006
14
0.480
 Why?
Exons
9
2013
34
0.480
 Why?
Attention Deficit Disorder with Hyperactivity
4
2020
18
0.480
 Why?
Drug-Related Side Effects and Adverse Reactions
3
2020
39
0.470
 Why?
Anticonvulsants
7
2020
25
0.470
 Why?
Computational Biology
5
2020
43
0.450
 Why?
Genetic Loci
5
2019
40
0.450
 Why?
Age Factors
10
2020
210
0.430
 Why?
Antimalarials
2
2023
6
0.430
 Why?
Gene Expression Regulation, Enzymologic
6
2015
20
0.430
 Why?
Oxygenases
2
2017
5
0.430
 Why?
Acetaminophen
4
2019
18
0.420
 Why?
Brain
3
2011
80
0.410
 Why?
Promoter Regions, Genetic
4
2018
49
0.410
 Why?
Phenytoin
3
2020
9
0.400
 Why?
Population
1
2011
2
0.400
 Why?
Clinical Decision-Making
3
2020
17
0.400
 Why?
Opioid-Related Disorders
3
2024
15
0.380
 Why?
Sulfotransferases
4
2019
7
0.380
 Why?
Substrate Specificity
9
2016
16
0.380
 Why?
DNA Primers
8
2015
30
0.370
 Why?
Models, Genetic
2
2007
33
0.370
 Why?
Mycological Typing Techniques
2
2007
3
0.360
 Why?
Multiplex Polymerase Chain Reaction
2
2021
9
0.360
 Why?
Ondansetron
2
2022
3
0.360
 Why?
Microfluidic Analytical Techniques
1
2010
3
0.360
 Why?
Warfarin
7
2018
12
0.360
 Why?
Disulfides
1
2010
2
0.360
 Why?
Indians, North American
3
2013
9
0.350
 Why?
Tandem Repeat Sequences
1
2010
7
0.350
 Why?
Dose-Response Relationship, Drug
12
2020
94
0.350
 Why?
DNA, Fungal
2
2007
6
0.350
 Why?
Xanthine Oxidase
8
2010
14
0.340
 Why?
Debrisoquin
4
2002
5
0.340
 Why?
Central Nervous System Stimulants
4
2016
11
0.340
 Why?
NAD(P)H Dehydrogenase (Quinone)
2
2000
5
0.340
 Why?
Algorithms
2
2019
105
0.330
 Why?
Drug Dosage Calculations
4
2018
16
0.330
 Why?
Benzoxazines
2
2019
2
0.320
 Why?
Immunosuppressive Agents
2
2022
31
0.320
 Why?
Breast Feeding
4
2011
25
0.310
 Why?
Anticoagulants
4
2018
20
0.310
 Why?
Cytochrome P-450 CYP2D6 Inhibitors
4
2020
11
0.310
 Why?
Epoxide Hydrolases
3
1997
6
0.310
 Why?
Adrenergic beta-Antagonists
2
2024
6
0.300
 Why?
Aged, 80 and over
8
2018
151
0.300
 Why?
Adrenergic Uptake Inhibitors
2
2019
6
0.300
 Why?
Fetus
2
2011
16
0.300
 Why?
Metabolomics
2
2020
18
0.300
 Why?
Healthy Volunteers
4
2021
8
0.290
 Why?
Fungal Proteins
1
2007
10
0.290
 Why?
Isoenzymes
8
2017
19
0.290
 Why?
Genetic Heterogeneity
1
2007
5
0.290
 Why?
Area Under Curve
10
2019
35
0.290
 Why?
Dextrorphan
8
2022
13
0.290
 Why?
Steroid 16-alpha-Hydroxylase
3
2001
6
0.290
 Why?
Steroid Hydroxylases
3
2001
10
0.290
 Why?
Breath Tests
2
2022
11
0.280
 Why?
Thailand
3
2021
3
0.280
 Why?
Bipolar Disorder
2
2016
4
0.270
 Why?
Ethanolamines
2
2005
4
0.270
 Why?
Pathology, Molecular
2
2023
3
0.270
 Why?
Gene Rearrangement
1
2006
7
0.270
 Why?
Baclofen
2
2017
9
0.260
 Why?
Trinidad and Tobago
2
2018
2
0.260
 Why?
Methyltransferases
2
2022
9
0.260
 Why?
HIV Infections
3
2019
50
0.260
 Why?
Gene Expression Regulation
2
2019
101
0.260
 Why?
Morphine
5
2021
11
0.260
 Why?
Gene Expression Regulation, Developmental
3
2015
51
0.260
 Why?
Cerebral Palsy
2
2017
18
0.260
 Why?
Polymorphism, Restriction Fragment Length
7
2013
9
0.260
 Why?
Reproducibility of Results
4
2019
199
0.250
 Why?
Antidepressive Agents, Tricyclic
2
2017
5
0.250
 Why?
Prevalence
2
2021
146
0.250
 Why?
Body Weight
3
2018
52
0.250
 Why?
Prospective Studies
7
2022
525
0.240
 Why?
Receptors, Adrenergic, beta-1
1
2024
1
0.240
 Why?
Receptors, Adrenergic, beta-2
1
2024
1
0.240
 Why?
G-Protein-Coupled Receptor Kinase 5
1
2024
1
0.240
 Why?
Nicotine
1
2024
10
0.240
 Why?
Methadone
1
2024
1
0.240
 Why?
Antitussive Agents
5
2010
13
0.240
 Why?
Cytochrome P-450 CYP1A2
6
2008
12
0.240
 Why?
Capecitabine
1
2024
1
0.240
 Why?
Transcription, Genetic
4
2013
44
0.230
 Why?
RNA, Fungal
1
2003
1
0.230
 Why?
DNA, Ribosomal
1
2003
3
0.230
 Why?
RNA, Ribosomal
1
2003
3
0.230
 Why?
Rosuvastatin Calcium
2
2022
5
0.230
 Why?
Testosterone
3
2020
30
0.230
 Why?
Citalopram
2
2023
14
0.230
 Why?
Antimetabolites, Antineoplastic
1
2024
26
0.230
 Why?
Genome-Wide Association Study
3
2023
190
0.220
 Why?
Netherlands
2
2021
4
0.220
 Why?
Indomethacin
1
2022
4
0.220
 Why?
Binding Sites
4
2017
26
0.210
 Why?
Tonsillectomy
1
2022
11
0.210
 Why?
Hydroxylation
6
2016
12
0.210
 Why?
Biomarkers
5
2020
136
0.210
 Why?
Cohort Studies
6
2017
289
0.210
 Why?
Anti-Arrhythmia Agents
1
2022
1
0.210
 Why?
Propafenone
1
2022
1
0.210
 Why?
Long QT Syndrome
1
2022
3
0.210
 Why?
Drug Prescriptions
2
2020
20
0.210
 Why?
Cyclosporine
1
2022
6
0.210
 Why?
Simvastatin
2
2022
10
0.200
 Why?
Prodrugs
1
2022
2
0.200
 Why?
Platelet Aggregation Inhibitors
1
2022
5
0.200
 Why?
Genetics, Medical
1
2022
5
0.200
 Why?
Cytosol
2
2019
14
0.200
 Why?
Antidepressive Agents, Second-Generation
2
2016
4
0.200
 Why?
Pain
2
2021
57
0.200
 Why?
Computer Simulation
3
2020
31
0.200
 Why?
Infant, Premature
1
2022
85
0.200
 Why?
Gene Deletion
2
2011
13
0.200
 Why?
Postoperative Nausea and Vomiting
2
2022
5
0.200
 Why?
Chromosome Mapping
2
2003
35
0.200
 Why?
Gastroesophageal Reflux
2
2020
41
0.200
 Why?
Proteins
1
2021
27
0.200
 Why?
Cluster Analysis
3
2015
43
0.200
 Why?
Pharmacokinetics
1
2021
14
0.200
 Why?
Animals
10
2010
729
0.200
 Why?
Carboxy-Lyases
1
2021
1
0.190
 Why?
Vitamin K Epoxide Reductases
1
2021
2
0.190
 Why?
Egypt
1
2021
1
0.190
 Why?
Arabs
1
2021
1
0.190
 Why?
Drug Interactions
7
2020
32
0.190
 Why?
Real-Time Polymerase Chain Reaction
2
2019
41
0.190
 Why?
Spain
2
2011
2
0.190
 Why?
Risperidone
1
2021
2
0.190
 Why?
Catechol O-Methyltransferase
1
2021
5
0.190
 Why?
Receptors, Opioid, mu
1
2021
4
0.190
 Why?
Carbamazepine
2
1998
10
0.190
 Why?
Milk, Human
3
2011
23
0.190
 Why?
Psychiatry
1
2020
1
0.190
 Why?
Genes
3
2015
10
0.190
 Why?
United States
4
2022
669
0.190
 Why?
HLA-B Antigens
1
2020
7
0.180
 Why?
Sertraline
2
2019
11
0.180
 Why?
Pimozide
1
2020
4
0.180
 Why?
Polymorphism, Single-Stranded Conformational
2
2019
4
0.180
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2020
7
0.180
 Why?
Caffeine
5
2010
13
0.180
 Why?
Cloning, Molecular
4
2005
8
0.180
 Why?
3' Untranslated Regions
2
2017
10
0.180
 Why?
Marketing of Health Services
1
2019
3
0.170
 Why?
Drug Labeling
1
2019
4
0.170
 Why?
Breast Neoplasms
2
2018
38
0.170
 Why?
Delphi Technique
1
2019
11
0.170
 Why?
Phenylethyl Alcohol
1
2019
1
0.170
 Why?
Wine
1
2019
1
0.170
 Why?
Schizophrenia
2
2010
3
0.170
 Why?
Cardiovascular System
1
2019
4
0.170
 Why?
Drug Resistance
1
2019
7
0.170
 Why?
Sequence Alignment
2
2015
11
0.170
 Why?
HIV-1
1
2019
26
0.170
 Why?
Metoprolol
3
2024
4
0.170
 Why?
Administration, Oral
8
2017
58
0.170
 Why?
Pravastatin
1
2019
7
0.160
 Why?
Treatment Outcome
5
2023
622
0.160
 Why?
Mutation, Missense
1
2018
28
0.160
 Why?
Glucuronides
1
2018
3
0.160
 Why?
Predictive Value of Tests
4
2020
99
0.160
 Why?
Proteomics
4
2021
24
0.160
 Why?
Drug Hypersensitivity
3
1996
19
0.160
 Why?
Growth Disorders
2
2008
25
0.160
 Why?
Population Surveillance
1
2018
13
0.160
 Why?
Autoantigens
1
1998
5
0.160
 Why?
Pharmacists
3
2023
4
0.160
 Why?
Androgens
1
2018
8
0.160
 Why?
Tamoxifen
1
2018
1
0.160
 Why?
Software
1
2018
30
0.150
 Why?
Indians, South American
1
2018
1
0.150
 Why?
Recombinant Proteins
5
2020
48
0.150
 Why?
Muscle Relaxants, Central
2
2017
7
0.150
 Why?
Surveys and Questionnaires
1
2019
274
0.150
 Why?
Kinetics
6
2008
31
0.150
 Why?
Cytochrome P-450 CYP2B6 Inducers
1
2017
1
0.150
 Why?
Aldehyde Dehydrogenase
1
2017
3
0.150
 Why?
Alcohol Dehydrogenase
1
2017
4
0.150
 Why?
Metabolic Clearance Rate
4
2014
18
0.150
 Why?
Hypersensitivity
1
1998
56
0.150
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2005
71
0.150
 Why?
Diabetic Neuropathies
1
2017
1
0.150
 Why?
Pilot Projects
5
2022
120
0.150
 Why?
Amitriptyline
1
2017
4
0.150
 Why?
Chromosomes, Human, Pair 16
1
1997
2
0.150
 Why?
Carboxylic Ester Hydrolases
1
2016
2
0.140
 Why?
Carboxylesterase
1
2016
2
0.140
 Why?
Oseltamivir
1
2016
6
0.140
 Why?
Sparteine
4
1998
4
0.140
 Why?
Depression
3
2023
69
0.140
 Why?
Mutation
5
2010
212
0.140
 Why?
Organic Anion Transporters, Sodium-Independent
1
2016
3
0.140
 Why?
Multidrug Resistance-Associated Proteins
1
2016
5
0.140
 Why?
Organic Cation Transporter 1
1
2016
4
0.140
 Why?
Hepatocytes
2
2013
8
0.140
 Why?
Fluoxetine
2
2014
5
0.140
 Why?
South Africa
3
2015
6
0.130
 Why?
Risk Assessment
4
2020
137
0.130
 Why?
RNA Splicing
2
2006
14
0.130
 Why?
Sulfates
3
2019
6
0.130
 Why?
Pediatric Obesity
1
2018
137
0.130
 Why?
Case-Control Studies
5
2019
215
0.130
 Why?
Gestational Age
1
2015
62
0.130
 Why?
Genomics
2
2022
101
0.130
 Why?
Sex Factors
5
2020
68
0.130
 Why?
Practice Guidelines as Topic
3
2020
108
0.130
 Why?
Enzyme Activation
2
2018
12
0.120
 Why?
False Negative Reactions
1
2014
9
0.120
 Why?
Mental Disorders
2
2013
16
0.120
 Why?
RNA
3
2005
14
0.120
 Why?
Research
1
2014
13
0.120
 Why?
Pregnancy
3
2021
216
0.120
 Why?
Risk Factors
4
2020
487
0.120
 Why?
Obsessive-Compulsive Disorder
2
2020
6
0.120
 Why?
COS Cells
3
2002
19
0.110
 Why?
Puerto Rico
2
2010
3
0.110
 Why?
Tramadol
2
2005
4
0.110
 Why?
Rifampin
1
2013
7
0.110
 Why?
Amphetamine-Related Disorders
1
2013
1
0.110
 Why?
Methamphetamine
1
2013
2
0.110
 Why?
Transition Temperature
1
2013
2
0.110
 Why?
Cardiomyopathy, Dilated
1
2013
9
0.110
 Why?
Kidney Transplantation
1
2014
115
0.110
 Why?
Heart Failure
1
2013
14
0.110
 Why?
India
1
2013
2
0.110
 Why?
Tandem Mass Spectrometry
3
2019
20
0.110
 Why?
Cross-Over Studies
6
2019
35
0.110
 Why?
Menstrual Cycle
3
2004
6
0.110
 Why?
Chromatography, High Pressure Liquid
4
2019
40
0.110
 Why?
Primaquine
2
2023
2
0.110
 Why?
Oxidoreductases, N-Demethylating
3
2003
8
0.100
 Why?
Flushing
1
2012
4
0.100
 Why?
Exanthema
1
2012
4
0.100
 Why?
Pruritus
1
2012
4
0.100
 Why?
Erythema
1
2012
5
0.100
 Why?
Longitudinal Studies
3
2022
119
0.100
 Why?
Clinical Trials as Topic
2
2010
45
0.100
 Why?
Vancomycin
1
2012
17
0.100
 Why?
Hepatocyte Nuclear Factor 4
1
2012
3
0.100
 Why?
Saliva
1
2011
10
0.100
 Why?
Blood
1
2011
10
0.100
 Why?
Parkinson Disease
1
2011
1
0.100
 Why?
Midazolam
4
2010
12
0.100
 Why?
Chromosomes, Human, Pair 22
1
1991
5
0.100
 Why?
Introns
2
2005
7
0.100
 Why?
Genetic Markers
2
2016
22
0.100
 Why?
Chromosome Deletion
1
1991
20
0.100
 Why?
Restriction Mapping
3
1997
6
0.090
 Why?
Hep G2 Cells
3
2017
6
0.090
 Why?
Retrospective Studies
3
2022
1296
0.090
 Why?
China
2
2001
9
0.090
 Why?
Canada
2
2001
31
0.090
 Why?
Hybridization, Genetic
1
2010
3
0.090
 Why?
Luciferases
2
2012
6
0.090
 Why?
Genes, Reporter
2
2012
13
0.090
 Why?
HLA Antigens
2
2020
13
0.090
 Why?
Genome, Human
1
2010
86
0.090
 Why?
Neoplasm Proteins
2
2022
31
0.090
 Why?
In Vitro Techniques
3
2017
23
0.080
 Why?
Gene Expression
2
2010
67
0.080
 Why?
Paroxetine
2
2006
3
0.080
 Why?
Growth Hormone
1
2008
6
0.080
 Why?
Alkynes
2
2019
2
0.080
 Why?
Cyclopropanes
2
2019
7
0.080
 Why?
Carbon Dioxide
1
2008
14
0.080
 Why?
Human Growth Hormone
1
2008
15
0.080
 Why?
Cells, Cultured
2
2013
84
0.080
 Why?
Abnormalities, Drug-Induced
1
2008
8
0.080
 Why?
Transfection
2
2012
22
0.080
 Why?
Linear Models
1
2007
56
0.070
 Why?
Heterozygote
3
2024
26
0.070
 Why?
Species Specificity
1
2007
10
0.070
 Why?
Scalp
1
2007
2
0.070
 Why?
Epitopes
2
1998
20
0.070
 Why?
Artifacts
1
2007
7
0.070
 Why?
Gene Amplification
1
2007
4
0.070
 Why?
Child Day Care Centers
1
2006
1
0.070
 Why?
Half-Life
4
2014
12
0.070
 Why?
Acetyltransferases
2
2003
4
0.070
 Why?
Urban Population
1
2006
27
0.070
 Why?
Rats
3
2010
106
0.070
 Why?
Amino Acid Sequence
4
1999
32
0.070
 Why?
Fatty Acids, Monounsaturated
1
2006
1
0.070
 Why?
Indoles
1
2006
3
0.070
 Why?
Benzimidazoles
1
2006
1
0.070
 Why?
Ribonucleosides
1
2006
1
0.070
 Why?
Smoking
1
2006
22
0.070
 Why?
Open Reading Frames
1
2006
3
0.070
 Why?
Ethinyl Estradiol
1
2005
2
0.070
 Why?
Norgestrel
1
2005
2
0.070
 Why?
Contraceptives, Oral
1
2005
3
0.070
 Why?
Mexican Americans
1
2005
2
0.070
 Why?
Antiviral Agents
1
2006
30
0.070
 Why?
Vitamin K
2
2005
5
0.070
 Why?
Patient Safety
2
2016
20
0.070
 Why?
Feasibility Studies
2
2020
58
0.070
 Why?
Cross-Sectional Studies
2
2021
336
0.060
 Why?
Pyrimidinones
1
2004
1
0.060
 Why?
Ritonavir
1
2004
1
0.060
 Why?
HIV Protease Inhibitors
1
2004
2
0.060
 Why?
Receptors, Adrenergic, alpha-2
1
2024
1
0.060
 Why?
Opiate Substitution Treatment
1
2024
2
0.060
 Why?
Mice
4
2010
348
0.060
 Why?
Blood Specimen Collection
1
2004
5
0.060
 Why?
Hypertension
1
2004
66
0.060
 Why?
Genes, Fungal
1
2003
1
0.060
 Why?
Genome, Fungal
1
2003
1
0.060
 Why?
DNA, Intergenic
1
2003
1
0.060
 Why?
Drosophila Proteins
1
2003
8
0.060
 Why?
Cystic Fibrosis
1
2004
18
0.060
 Why?
Chloroquine
1
2023
1
0.060
 Why?
Amino Acid Transport Systems
1
2003
1
0.060
 Why?
Membrane Proteins
1
2003
54
0.060
 Why?
Nuclear Proteins
1
2003
52
0.060
 Why?
Serotonin
1
2023
4
0.060
 Why?
Serotonin Plasma Membrane Transport Proteins
1
2023
7
0.060
 Why?
Carrier Proteins
1
2003
35
0.060
 Why?
Stereoisomerism
4
2006
9
0.050
 Why?
Forecasting
1
2022
22
0.050
 Why?
Multigene Family
2
2019
8
0.050
 Why?
Cyclooxygenase Inhibitors
1
2002
4
0.050
 Why?
Africa
1
2022
3
0.050
 Why?
Asia
1
2022
10
0.050
 Why?
Ticlopidine
1
2022
2
0.050
 Why?
NADPH-Ferrihemoprotein Reductase
1
2021
2
0.050
 Why?
Mutagenesis, Site-Directed
2
1999
19
0.050
 Why?
Antifibrinolytic Agents
1
2001
3
0.050
 Why?
Recombinant Fusion Proteins
2
1999
13
0.050
 Why?
Paliperidone Palmitate
1
2021
2
0.050
 Why?
Sensitivity and Specificity
3
2008
150
0.050
 Why?
Societies, Medical
1
2021
51
0.050
 Why?
Supervised Machine Learning
1
2020
2
0.050
 Why?
Urea Cycle Disorders, Inborn
1
2020
2
0.050
 Why?
Prescription Drugs
1
2020
4
0.050
 Why?
Academic Medical Centers
1
2020
11
0.050
 Why?
Esophagitis
1
2020
7
0.050
 Why?
Gastritis
1
2020
12
0.050
 Why?
Tourette Syndrome
1
2020
6
0.050
 Why?
Amines
2
1997
4
0.050
 Why?
Stevens-Johnson Syndrome
1
2020
14
0.050
 Why?
Methylation
2
2016
11
0.040
 Why?
Catecholamines
1
1999
7
0.040
 Why?
Sequence Deletion
1
2019
12
0.040
 Why?
Leukocytes, Mononuclear
1
2019
16
0.040
 Why?
Drug Combinations
3
2005
19
0.040
 Why?
Gas Chromatography-Mass Spectrometry
2
2013
2
0.040
 Why?
Anti-HIV Agents
1
2019
9
0.040
 Why?
Acetylation
3
2007
3
0.040
 Why?
Hospitals, Pediatric
1
2020
187
0.040
 Why?
Genetic Predisposition to Disease
2
2013
231
0.040
 Why?
Excitatory Amino Acid Antagonists
3
2005
6
0.040
 Why?
Zidovudine
1
2018
2
0.040
 Why?
Antimetabolites
1
2018
4
0.040
 Why?
Homozygote
3
1998
20
0.040
 Why?
Thromboxane-A Synthase
1
1998
2
0.040
 Why?
Intramolecular Oxidoreductases
1
1998
2
0.040
 Why?
Epitope Mapping
1
1998
7
0.040
 Why?
Fathers
1
2018
7
0.040
 Why?
Internet
1
2018
17
0.040
 Why?
Hyperlipidemias
1
2018
6
0.040
 Why?
Antineoplastic Agents, Hormonal
1
2018
3
0.040
 Why?
Mothers
1
2018
33
0.040
 Why?
Microsomes
2
1995
5
0.040
 Why?
Neoplasm Recurrence, Local
1
2018
31
0.040
 Why?
Escherichia coli
1
1998
30
0.040
 Why?
Sulfonylurea Receptors
1
2017
7
0.040
 Why?
Sex Characteristics
1
2017
12
0.040
 Why?
Follow-Up Studies
1
2018
304
0.040
 Why?
Double-Blind Method
2
2008
44
0.040
 Why?
Carcinogens
1
1997
1
0.040
 Why?
Xenobiotics
1
1997
3
0.040
 Why?
Heterocyclic Compounds
1
1997
3
0.040
 Why?
Serotonin 5-HT3 Receptor Agonists
1
2017
1
0.040
 Why?
Random Allocation
1
2017
7
0.040
 Why?
Radiotherapy
1
2017
5
0.040
 Why?
Antiemetics
1
2017
4
0.040
 Why?
Sequence Homology, Nucleic Acid
1
1997
4
0.040
 Why?
Analgesics, Non-Narcotic
1
2017
8
0.040
 Why?
Chromatography, Liquid
1
2016
9
0.040
 Why?
Prognosis
1
2017
211
0.040
 Why?
Propylamines
1
2016
4
0.030
 Why?
Phenols
1
2016
7
0.030
 Why?
Therapeutic Equivalency
2
2006
5
0.030
 Why?
Drug Monitoring
1
2016
13
0.030
 Why?
Reference Values
2
2008
39
0.030
 Why?
Research Design
1
2016
63
0.030
 Why?
Quality Improvement
1
2016
60
0.030
 Why?
Mice, Knockout
2
2007
59
0.030
 Why?
Gene Expression Profiling
1
2015
126
0.030
 Why?
Clotrimazole
1
2014
3
0.030
 Why?
DNA, Complementary
1
1994
9
0.030
 Why?
Point Mutation
1
1994
7
0.030
 Why?
Anti-Infective Agents, Local
1
2014
8
0.030
 Why?
Pedigree
2
2011
59
0.030
 Why?
Absorption
1
2014
7
0.030
 Why?
Drug Administration Schedule
1
2014
35
0.030
 Why?
Multivariate Analysis
1
2014
71
0.030
 Why?
Models, Statistical
1
2014
29
0.030
 Why?
Adrenal Cortex Hormones
1
2014
37
0.030
 Why?
Northwestern United States
1
2013
1
0.030
 Why?
Linkage Disequilibrium
1
2013
34
0.030
 Why?
Substance Abuse Detection
1
2013
1
0.030
 Why?
Natriuretic Peptide, Brain
1
2013
6
0.030
 Why?
Chi-Square Distribution
1
2013
33
0.030
 Why?
Odds Ratio
1
2013
51
0.030
 Why?
Enzyme Inhibitors
2
2006
21
0.030
 Why?
Logistic Models
1
2013
84
0.030
 Why?
Aminosalicylic Acid
2
2007
2
0.030
 Why?
Amine Oxidase (Copper-Containing)
1
2012
6
0.030
 Why?
Syndrome
1
2012
34
0.030
 Why?
Catalysis
2
2005
4
0.030
 Why?
Histamine
1
2012
13
0.030
 Why?
HeLa Cells
1
2012
17
0.030
 Why?
Plasmids
1
2012
5
0.030
 Why?
Postmortem Changes
1
2011
1
0.020
 Why?
Oxidation-Reduction
1
1991
9
0.020
 Why?
Immunohistochemistry
2
2005
48
0.020
 Why?
Follicular Phase
2
2002
3
0.020
 Why?
Luteal Phase
2
2002
3
0.020
 Why?
Hydrogen-Ion Concentration
1
2010
19
0.020
 Why?
Systems Biology
1
2010
4
0.020
 Why?
Hospitalization
1
2012
210
0.020
 Why?
Interleukin-6
1
2010
12
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2010
15
0.020
 Why?
Catalytic Domain
2
1999
4
0.020
 Why?
In Situ Hybridization
2
2000
11
0.020
 Why?
Tissue Distribution
2
2000
11
0.020
 Why?
Dwarfism, Pituitary
1
2008
1
0.020
 Why?
Carbon Isotopes
1
2008
4
0.020
 Why?
Probability
1
2008
15
0.020
 Why?
Insulin-Like Growth Factor I
1
2008
8
0.020
 Why?
Apnea
1
2008
5
0.020
 Why?
Dopamine
2
1999
5
0.020
 Why?
Infusions, Intravenous
1
2008
26
0.020
 Why?
Sequence Homology, Amino Acid
2
1999
6
0.020
 Why?
Aminobiphenyl Compounds
1
2007
1
0.020
 Why?
Fluorenes
1
2007
1
0.020
 Why?
Sulfamethazine
1
2007
1
0.020
 Why?
Dealkylation
1
2007
2
0.020
 Why?
Fatal Outcome
1
2007
7
0.020
 Why?
Mice, Inbred C57BL
1
2007
92
0.020
 Why?
Psychometrics
1
2006
30
0.020
 Why?
Dehydroepiandrosterone
1
2005
2
0.020
 Why?
Time Factors
1
2006
250
0.020
 Why?
Lopinavir
1
2004
1
0.020
 Why?
Blood Pressure
1
2004
67
0.020
 Why?
Seizures
1
2004
25
0.010
 Why?
Confidence Intervals
1
2004
12
0.010
 Why?
Phosphodiesterase Inhibitors
1
2003
4
0.010
 Why?
Vitamins
1
2003
11
0.010
 Why?
Electrophoresis, Gel, Pulsed-Field
1
2003
2
0.010
 Why?
Biological Availability
1
2003
8
0.010
 Why?
Amino Acid Transport System A
1
2003
1
0.010
 Why?
Fluvoxamine
1
2002
2
0.010
 Why?
Least-Squares Analysis
1
2002
2
0.010
 Why?
International Normalized Ratio
1
2001
4
0.010
 Why?
Anti-Anxiety Agents
1
2000
5
0.010
 Why?
Hypnotics and Sedatives
1
2000
6
0.010
 Why?
RNA Probes
1
2000
1
0.010
 Why?
Histocytochemistry
1
2000
4
0.010
 Why?
Crystallization
1
1999
1
0.010
 Why?
Hydrogen Bonding
1
1999
1
0.010
 Why?
Protein Structure, Secondary
1
1999
1
0.010
 Why?
Crystallography, X-Ray
1
1999
4
0.010
 Why?
Conserved Sequence
1
1999
5
0.010
 Why?
Models, Molecular
1
1999
14
0.010
 Why?
Cytochrome P-450 Enzyme Inhibitors
1
1999
6
0.010
 Why?
Phosphoadenosine Phosphosulfate
1
1999
1
0.010
 Why?
Nitrophenols
1
1999
2
0.010
 Why?
Analysis of Variance
1
1998
22
0.010
 Why?
Evaluation Studies as Topic
1
1998
8
0.010
 Why?
Enzyme Stability
1
1998
3
0.010
 Why?
Germany
1
1998
6
0.010
 Why?
Haptens
1
1996
3
0.010
 Why?
Cytochrome P-450 CYP2E1
1
1996
4
0.010
 Why?
Binding Sites, Antibody
1
1996
4
0.010
 Why?
Consensus Sequence
1
1996
3
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
1996
9
0.010
 Why?
Gene Library
1
1996
5
0.010
 Why?
Blotting, Western
1
1996
17
0.010
 Why?
Peptide Fragments
1
1996
12
0.010
 Why?
Antibodies
1
1996
15
0.010
 Why?
Disease Susceptibility
1
1995
11
0.010
 Why?
Deoxyribonucleases, Type II Site-Specific
1
1990
2
0.010
 Why?
Urinary Bladder Neoplasms
1
1990
3
0.010
 Why?
Lung Neoplasms
1
1990
23
0.010
 Why?
Gaedigk's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (578) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_